ALPL and hypophosphatasia: This finding is in line with the effect of several rare loss-of-function variants in ALPL that have been reported in patients with hypophosphatasia (OMIM:146300), a syndrome characterized by decreased levels of ALP and elevated urine pyrophosphate 21, a known inhibitor of kidney stone formation4.